Mankind Pharma Ltd Share Price – NSE /  BSE

Pharmaceuticals, Mid Cap

The board of Mankind Pharma at its meeting held on 11 July 2026, has inter-alia, considered and approved the:

1. proposal for divestment of 100% stake held in Broadway Hospitality Services (Broadway), a wholly owned subsidiary company; and
2. incorporation of a wholly owned subsidiary company in Netherlands (WOS) to act as a Special Purpose Vehicle for holding investments in R&D assets and business development activities focused on treatment of niche therapies.

Mankind Pharma announced that the 35th Annual General Meeting(AGM) of the company will be held on 4 August 2026.

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.11% on the day, quoting at 23888.4. The Sensex is at 75882.34, down 0.17%.Mankind Pharma Ltd has gained around 6.53% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 6.66% in last one month and is currently quoting at 24659.2, up 0.16% on the day. The volume in the stock stood at 3.04 lakh shares today, compared to the daily average of 7.96 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 2429.3, down 0.46% on the day. Mankind Pharma Ltd tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index.

The PE of the stock is 47.06 based on TTM earnings ending March 26.

Powered by Capital Market - Live News

Mankind Pharma has allotted 80,872 equity shares under ESOP on 19 May 2026. Consequently, the paid up equity share capital has increased to 41,29,09,200 equity shares having face value of Re 1/- each.